Trial Profile
Open-Label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact of Disease Score, in Rheumatoid Arthritis Patients Eligible to Etanercept and Who Will Receive Etanercept.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Rainbow
- Sponsors Wyeth
- 22 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2009 Actual initiation date (Oct 2008) added as reported by ClinicalTrials.gov.
- 24 Nov 2008 Status changed from not yet recruiting to recruiting.